| Cas No.: | 2058116-52-0 |
| Chemical Name: | 1-(5-Amino-2,3-dihydro-1H-inden-2-yl)-3-(8-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| Synonyms: | MDVN1003;1-(5-amino-2,3-dihydro-1H-inden-2-yl)-3-(8-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;BDBM50201726 |
| SMILES: | FC1C2=C(C([H])=C(C=1[H])C1C3=C(N([H])[H])N=C([H])N=C3N(C3([H])C([H])([H])C4C([H])=C([H])C(=C([H])C=4C3([H])[H])N([H])[H])N=1)N([H])C([H])([H])C([H])([H])O2 |
| Formula: | C22H20FN7O |
| M.Wt: | 417.4389 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | MDVN1003 is a potent inhibitor of BTK amd PI3K delta. |
| In Vitro: | MDVN1003 is a potent inhibitor of BTK amd PI3K delta. MDVN1003 inhibits Bruton's tyrosine kinase (BTK) and phosphatidylinositol-3-kinase delta (PI3K��), two proteins regulated by the B cell receptor (BCR) that drive the growth of many NHLs. MDVN1003 induces cell death in a B cell lymphoma cell line but not in an irrelevant erythroblast cell line. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
